News

Cognota receives US FDA approval for BP monitor device 

The regulatory approval is a significant milestone for Cognota which can now export its blood pressure monitor devices to the US, Europe, and other overseas countries

Leading health tech company Cognota Healthcare announced that the United States Food and Drug Administration (US FDA) has approved the company’s blood pressure monitor device- ‘COGNOHEALTH Blood Pressure Monitor’, marking the successful foray of the company into the medical devices segment.

The regulatory approval is a significant milestone for Cognota which can now export its blood pressure monitor devices to the US, Europe, and other overseas countries along with tapping the burgeoning Indian market.

The ‘COGNOHEALTH Blood Pressure Monitor’ device is powered by state-of-the-art technology that has been designed and developed by experts in Cognota’s R&D team. Approval from the US FDA, one of the apex healthcare regulatory bodies of the world, enables Cognota to expand its existing portfolio of health tech solutions that include Remote Patient Monitoring (RPM), Teleconsultation Platform, and Smart ICU among others. 

In a short span, Cognota has emerged as a market leader in multiple critical health tech solutions by embedding cutting-edge software solutions in hardware devices. With such successful integration, its health tech solutions are being increasingly adopted by several marquee healthcare providers across the world. US FDA approval is likely to provide further traction to the current momentum.

Commenting on the US FDA approval of Cognota’s BP Monitoring device, Sanjeev Dahiwadkar, Founder & CEO, Cognota Healthcare said, “Hypertension is a critical health problem across the world given the current lifestyle and expectations of people. This silent killer disease is also a huge problem in India after diabetes. Therefore, the US FDA approval of ‘COGNOHEALTH Blood Pressure Monitor’ device is a huge leap in Cognota’s efforts towards addressing this challenge. Built in-house by our R&D team, this approval also vindicates Cognota’s expertise in the successful integration of digital applications with advanced hardware components.”

“US FDA approval is a rigorous process that investigates all aspects of a healthcare device. Therefore, approval of the COGNOHEALTH Blood Pressure Monitor device is a feather in Cognota’s cap, which showcases Cognota’s technological depth, R&D bandwidth, and talent base,” he said.

 

Support us in our endeavor to bring you Advertisement free content.
Choose your options to donate or subscribe.

Tags

Related Articles

Back to top button
Close
Close